Last checked at 17 Nov 2021 09:21
GSK gets USD1 billion US deals; Nucala is approved for three diseases
GSK gets USD1 billion US deals; Nucala is approved for three diseases
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades9,857
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,640.50
Bid:
1,640.00
Ask:
1,640.50
Change:
4.50 (0.28%)
Spread:
0.50 (0.03%)
Open:
1,642.00
High:
1,656.00
Low:
1,635.00
Prev. Close:
1,640.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.17 Nov 2021 07:50
EU approves Glaxo's Nucala treatment
(Sharecast News) - GlaxoSmithKline said the European Commission has approved its Nucala treatment for asthma and other nasal conditions.
Read more17 Nov 2021 07:28
UPDATE 3-U.S. secures GSK-Vir COVID-19 antibody therapy doses worth $1 bln
* Globally more than 750,000 doses of treatment secured* U.S. supply expected by mid-December* U.S. gave the drug emergency use approval in May (Writes through with detail)By Pushkala AripakaNov 17 (Reuters) - The United States has signed contracts ...
Read more17 Nov 2021 07:28
UPDATE 2-U.S. secures GSK-Vir COVID-19 antibody drug doses worth $1 bln
* Globally more than 750,000 doses of treatment secured* U.S. supply expected by mid-December* U.S. gave the drug emergency use approval in May (Adds detail on drug, exec comment, background)By Pushkala AripakaNov 17 (Reuters) - The United States ha...
Read more16 Nov 2021 10:03
UPDATE 2-AstraZeneca drags FTSE 100 lower, Vodafone surges on outlook
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Diageo rises on strong mid-term forecast* Strong jobs data cements rate-hike expectations* Vodafone gains on updated cashflow outlook* FTSE...
Read more12 Nov 2021 14:23
GlaxoSmithKline Comet trial in Covid vaccine meets primary endpoint
GlaxoSmithKline Comet trial in Covid vaccine meets primary endpoint
Read more12 Nov 2021 13:44
UPDATE 1-GSK-Vir COVID-19 antibody works as shot in the arm as well as infusion
(Adds background on rival products)By Ludwig Burger and Pushkala AripakaNov 12 (Reuters) - Britain's GSK and partner Vir said on Friday their antibody-based COVID-19 drug was shown in a trial to work as well when given as a shot in the arm awhen a...
Read more11 Nov 2021 15:49
11 Nov 2021 10:05
LONDON BROKER RATINGS: Capital & Counties and Shaftesbury get upgrades
LONDON BROKER RATINGS: Capital & Counties and Shaftesbury get upgrades
Read more8 Nov 2021 09:40
LONDON BROKER RATINGS: Bernstein downgrades IAG and Ryanair
LONDON BROKER RATINGS: Bernstein downgrades IAG and Ryanair
Read more5 Nov 2021 17:30
GSK says anaemia drug shows positive safety profile
By Ludwig BurgerNov 5 (Reuters) - GlaxoSmithKline said its anaemia pill for patients with kidney disease was shown to have about the same side effect risk as the current standard treatment in two important patient groups, a key advantage in a tigh...
Read more5 Nov 2021 09:56
UPDATE 2-Banks, energy shares lift FTSE 100; IAG jumps on recovery hopes
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* IAG gains on optimism around reopening of transatlantic travel* Pound extends losses after BoE leaves rates unchanged* FTSE 100 up 0.3%, F...
Read more5 Nov 2021 09:50
LONDON BROKER RATINGS: StanChart and Flutter upped to Buy; THG cut
LONDON BROKER RATINGS: StanChart and Flutter upped to Buy; THG cut
Read more3 Nov 2021 23:30
Older HPV vaccine cuts cervical cancer rate up to 87%, study finds
By Pushkala AripakaNov 3 (Reuters) - Young women who were vaccinated against human papillomavirus (HPV) in their teens with an older GlaxoSmithKline product called Cervarix had up to an 87% lower risk of developing cervical cancer linked to the vi...
Read more2 Nov 2021 14:50
UPDATE 2-Lilly pulls COVID-19 treatment from EU review while U.S. stocks up
(Adds details on U.S. status, EU purchases and priorities)By Pushkala Aripaka and Ludwig BurgerNov 2 (Reuters) - Eli Lilly has retracted a request for European Union approval of its antibody-based treatment for COVID-19, citing a lack of demand fro...
Read more